Axa S.A. Vertex Pharmaceuticals Inc Transaction History

Axa S.A.

$32.2 Billion
Q4 2024

A detailed history of Axa S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Axa S.A. holds 140,790 shares of VRTX stock, worth $66.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

140,790

Previous 144,410 2.51%

Holding current value

$66.4 Million

Previous $67.2 Million 15.58%

% of portfolio

0.18%

Previous 0.21%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$396.64 - $516.74 $1.44 Million - $1.87 Million	-3,620 Reduced 2.51%	140,790 $56.7 Million
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $22.5 Million - $24.7 Million	-48,927 Reduced 25.31%	144,410 $67.2 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $14.4 Million - $17.7 Million	-36,554 Reduced 15.9%	193,337 $90.6 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $17.7 Million - $19.4 Million	-43,470 Reduced 15.9%	229,891 $96.1 Million
Q4 2023 Jul 16, 2024	BUY	$343.0 - $410.68 $14.9 Million - $17.9 Million	43,470 Added 18.91%	273,361 $111 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $4.22 Million - $5.06 Million	-12,314 Reduced 4.31%	273,361 $111 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $3.49 Million - $3.74 Million	10,329 Added 3.75%	285,675 $99.3 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $8.99 Million - $10.1 Million	-28,607 Reduced 9.41%	275,346 $96.9 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $11.3 Million - $12.8 Million	-39,737 Reduced 11.56%	303,953 $95.8 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $18.9 Million - $21.3 Million	66,193 Added 23.85%	343,690 $99.3 Million
Q3 2022 Feb 14, 2023	BUY	$273.83 - $305.53 $11.9 Million - $13.3 Million	43,581 Added 18.63%	277,497 $80.3 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $11.9 Million - $13.3 Million	43,581 Added 18.63%	277,497 $80.3 Million
Q2 2022 Feb 14, 2023	SELL	$234.96 - $292.55 $17.3 Million - $21.6 Million	-73,703 Reduced 23.96%	233,916 $65.9 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $17.3 Million - $21.6 Million	-73,703 Reduced 23.96%	233,916 $65.9 Million
Q1 2022 Feb 14, 2023	BUY	$221.42 - $260.97 $6.67 Million - $7.86 Million	30,122 Added 10.85%	307,619 $80.3 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $21.8 Million - $25.7 Million	-98,580 Reduced 24.27%	307,619 $80.3 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $2.78 Million - $3.51 Million	-15,690 Reduced 3.72%	406,199 $89.2 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $36.1 Million - $40.4 Million	198,955 Added 89.24%	421,889 $76.5 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $2.22 Million - $2.61 Million	-11,825 Reduced 5.04%	222,934 $45 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $15.4 Million - $17.9 Million	-74,326 Reduced 24.05%	234,759 $50.4 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $6.39 Million - $8.53 Million	-30,879 Reduced 9.08%	309,085 $73 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $33.6 Million - $39.8 Million	-131,440 Reduced 27.88%	339,964 $92.5 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $10.5 Million - $13.8 Million	46,653 Added 10.98%	471,404 $137 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $5.12 Million - $6.36 Million	25,645 Added 6.43%	424,751 $101 Million
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $18 Million - $24.2 Million	108,147 Added 37.17%	399,106 $87.4 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $28.2 Million - $31.7 Million	-169,430 Reduced 36.8%	290,959 $49.3 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $12.7 Million - $14.7 Million	-76,979 Reduced 14.33%	460,389 $84.4 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $2.5 Million - $2.98 Million	-15,291 Reduced 2.77%	537,368 $98.8 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $3.05 Million - $3.86 Million	20,083 Added 3.77%	552,659 $91.6 Million
Q3 2018 Nov 08, 2018	SELL	$167.73 - $192.74 $45.5 Million - $52.3 Million	-271,505 Reduced 33.77%	532,576 $103 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $16.8 Million - $19.5 Million	114,996 Added 16.69%	804,081 $137 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $64.7 Million - $75.6 Million	426,971 Added 162.9%	689,085 $112 Million
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $1.66 Million - $1.88 Million	-12,084 Reduced 4.41%	262,114 $39.3 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $40.6 Million - $44.5 Million	274,198	274,198 $41.7 Million

Others Institutions Holding VRTX

# of Institutions

1,751

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account